BiondVax Pharmaceuticals Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. BiondVax Pharmaceuticals prevailing Real Value cannot be determined due to lack of data. The current price of BiondVax Pharmaceuticals is $0.0. Our model approximates the value of BiondVax Pharmaceuticals from analyzing the firm fundamentals such as Shares Owned By Insiders of 20.01 %, current valuation of 21.94 M, and Return On Equity of -56.02 as well as examining its technical indicators and probability of bankruptcy.
BiondVax Pharmaceuticals Total Value Analysis
BiondVax Pharmaceuticals is currently anticipated to have valuation of 21.94 M with market capitalization of 4.97 M, debt of 21.54 M, and cash on hands of 14.55 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the BiondVax Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
21.94 M | 4.97 M | 21.54 M | 14.55 M |
BiondVax Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of BiondVax is to check how much profit was generated for every dollar of assets it reports. BiondVax Pharmaceuticals shows a negative utilization of assets of -0.31 percent, losing $0.003089 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of BiondVax Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.BiondVax Pharmaceuticals Ownership Allocation
BiondVax Pharmaceuticals retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.BiondVax Pharmaceuticals Profitability Analysis
Net Loss for the year was (5.8 M) with profit before overhead, payroll, taxes, and interest of 0.BiondVax Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as BiondVax Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 754.1 B |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in BiondVax Stock
If you are still planning to invest in BiondVax Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BiondVax Pharmaceuticals' history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |